Feng‐Liang Liu

SARS-CoV-2 M ^pro inhibitors with antiviral activity in a transgenic mouse model

Jingxin Qiao, Yueshan Li, Rui Zeng et al. · Science · 2021 · 450 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target

Bingqing Xia, Xu-Rui Shen, Yang He et al. · Cell Research · 2021 · 198 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models

Gan Wang, Mengli Yang, Zilei Duan et al. · Cell Research · 2020 · 120 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

A nanomaterial targeting the spike protein captures SARS-CoV-2 variants and promotes viral elimination

Guofang Zhang, Yalin Cong, Feng‐Liang Liu et al. · Nature Nanotechnology · 2022 · 118 citations · Full text

Life Sciences, Infectious Diseases, Pharmaceutics +15

Review on wind power development in China: Current situation and improvement strategies to realize future development

Sheng-Peng Sun, Feng‐Liang Liu, Song Xue et al. · Renewable and Sustainable Energy Reviews · 2015 · 96 citations

Agriculture, Economic Development Planning, Environmental Engineering +17